Lots and lots of updates from the past weekend's ASCO annual meeting.

1. ADRIATIC (consolidation durvalumab in limited stage SCLC)
2. NADINA (neoadjuvant Nivo/Ipi in stage III melanoma)
3. *NICHE-2 (neoadjuvant Nivo/Ipi in dMMR colon cancer)
4. CheckMate 8HW (Nivo/Ipi in dMMR metastatic colon cancer)
5. TRANSMET (liver transplantation in colon cancer with liver mets)
6. Eposec (FLOT > CROSS in adenocarcinoma of the esophagus)
7. LAURA (forever osimertinib in stage III EGFR-mutated NSCLC post-chemoRT)
8. CROWN (5 year update of lorlatinib in ALK+ NSCLC)
9. Destiny Breast-06 (T-DXd vs. chemo in HER-2 low and "ultra" low MBC who haven't received chemo in metastatic setting)
10. ASC4FIRST (Asciminib first line in CML. Funny title, amirite?)

Ver todos los episodios